Affinity DataKi: 0.100nMAssay Description:Compound was evaluated for the inhibition of adenosine deaminaseMore data for this Ligand-Target Pair
Affinity DataKi: 0.100nMAssay Description:Compound was evaluated for the inhibition of adenosine deaminaseMore data for this Ligand-Target Pair
Affinity DataKi: 2nMAssay Description:Compound was evaluated for the inhibition of adenosine deaminaseMore data for this Ligand-Target Pair
Affinity DataKi: 80nMAssay Description:Compound was evaluated for the inhibition of adenosine deaminaseMore data for this Ligand-Target Pair
Affinity DataKi: 122nMAssay Description:Compound was evaluated for the inhibition of adenosine deaminaseMore data for this Ligand-Target Pair
Affinity DataKi: 500nMAssay Description:Compound was evaluated for the inhibition of adenosine deaminaseMore data for this Ligand-Target Pair
Affinity DataKi: 500nMAssay Description:Compound was evaluated for the inhibition of adenosine deaminaseMore data for this Ligand-Target Pair
Affinity DataKi: 1.41E+6nMAssay Description:Tested for inhibition against human plasma adenosine deaminase (ADA2)More data for this Ligand-Target Pair
Affinity DataKi: 2.18E+6nMAssay Description:Tested for binding constant against adenosine deaminase (ADA2) in human plasmaMore data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Development Center For Biotechnology
Curated by ChEMBL
Development Center For Biotechnology
Curated by ChEMBL
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Development Center For Biotechnology
Curated by ChEMBL
Development Center For Biotechnology
Curated by ChEMBL
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Development Center For Biotechnology
Curated by ChEMBL
Development Center For Biotechnology
Curated by ChEMBL
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Development Center For Biotechnology
Curated by ChEMBL
Development Center For Biotechnology
Curated by ChEMBL
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Development Center For Biotechnology
Curated by ChEMBL
Development Center For Biotechnology
Curated by ChEMBL
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Development Center For Biotechnology
Curated by ChEMBL
Development Center For Biotechnology
Curated by ChEMBL
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Development Center For Biotechnology
Curated by ChEMBL
Development Center For Biotechnology
Curated by ChEMBL
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Development Center For Biotechnology
Curated by ChEMBL
Development Center For Biotechnology
Curated by ChEMBL
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Development Center For Biotechnology
Curated by ChEMBL
Development Center For Biotechnology
Curated by ChEMBL
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Development Center For Biotechnology
Curated by ChEMBL
Development Center For Biotechnology
Curated by ChEMBL
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Development Center For Biotechnology
Curated by ChEMBL
Development Center For Biotechnology
Curated by ChEMBL
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Development Center For Biotechnology
Curated by ChEMBL
Development Center For Biotechnology
Curated by ChEMBL
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Development Center For Biotechnology
Curated by ChEMBL
Development Center For Biotechnology
Curated by ChEMBL
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Development Center For Biotechnology
Curated by ChEMBL
Development Center For Biotechnology
Curated by ChEMBL
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Development Center For Biotechnology
Curated by ChEMBL
Development Center For Biotechnology
Curated by ChEMBL
TargetReplicase polyprotein 1a(Human SARS coronavirus (SARS-CoV))
Development Center For Biotechnology
Curated by ChEMBL
Development Center For Biotechnology
Curated by ChEMBL
Affinity DataIC50: 950nMAssay Description:In vitro inhibitory concentration against SARS coronavirus main protease (SARS CoV 3C-like protease)More data for this Ligand-Target Pair
TargetReplicase polyprotein 1a(Human SARS coronavirus (SARS-CoV))
Development Center For Biotechnology
Curated by ChEMBL
Development Center For Biotechnology
Curated by ChEMBL
Affinity DataIC50: 980nMAssay Description:In vitro inhibitory concentration SARS coronavirus main protease (SARS CoV 3C-like protease) More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human topoisomerase 1More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+3nMAssay Description:In vitro inhibitory concentration against Chymotrypsin (serine protease)More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Development Center For Biotechnology
Curated by ChEMBL
Development Center For Biotechnology
Curated by ChEMBL
Affinity DataIC50: 1.36E+3nMAssay Description:Inhibition of EGFRMore data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Development Center For Biotechnology
Curated by ChEMBL
Development Center For Biotechnology
Curated by ChEMBL
Affinity DataIC50: 1.64E+3nMAssay Description:Inhibition of EGFRMore data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Development Center For Biotechnology
Curated by ChEMBL
Development Center For Biotechnology
Curated by ChEMBL
Affinity DataIC50: 1.64E+3nMAssay Description:Inhibition of EGFRMore data for this Ligand-Target Pair
TargetReplicase polyprotein 1a(Human SARS coronavirus (SARS-CoV))
Development Center For Biotechnology
Curated by ChEMBL
Development Center For Biotechnology
Curated by ChEMBL
Affinity DataIC50: 2.00E+3nMAssay Description:In vitro inhibitory concentration against SARS coronavirus main protease (SARS CoV 3C-like protease)More data for this Ligand-Target Pair
TargetReplicase polyprotein 1a(Human SARS coronavirus (SARS-CoV))
Development Center For Biotechnology
Curated by ChEMBL
Development Center For Biotechnology
Curated by ChEMBL
Affinity DataIC50: 4.82E+3nMAssay Description:In vitro inhibitory concentration against SARS coronavirus main protease (SARS CoV 3C-like protease)More data for this Ligand-Target Pair
TargetReplicase polyprotein 1a(Human SARS coronavirus (SARS-CoV))
Development Center For Biotechnology
Curated by ChEMBL
Development Center For Biotechnology
Curated by ChEMBL
Affinity DataIC50: 7.20E+3nMAssay Description:In vitro inhibitory concentration against SARS coronavirus main protease (SARS CoV 3C-like protease)More data for this Ligand-Target Pair
Affinity DataIC50: 7.20E+3nMAssay Description:Inhibition of human topoisomerase 1More data for this Ligand-Target Pair
TargetReplicase polyprotein 1a(Human SARS coronavirus (SARS-CoV))
Development Center For Biotechnology
Curated by ChEMBL
Development Center For Biotechnology
Curated by ChEMBL
Affinity DataIC50: 9.40E+3nMAssay Description:In vitro inhibitory concentration against SARS coronavirus main protease (SARS CoV 3C-like protease)More data for this Ligand-Target Pair
Affinity DataIC50: 1.04E+4nMAssay Description:In vitro inhibitory concentration against Chymotrypsin (serine protease)More data for this Ligand-Target Pair
TargetReplicase polyprotein 1a(Human SARS coronavirus (SARS-CoV))
Development Center For Biotechnology
Curated by ChEMBL
Development Center For Biotechnology
Curated by ChEMBL
Affinity DataIC50: 1.12E+4nMAssay Description:In vitro inhibitory concentration against SARS coronavirus main protease (SARS CoV 3C-like protease)More data for this Ligand-Target Pair
TargetReplicase polyprotein 1a(Human SARS coronavirus (SARS-CoV))
Development Center For Biotechnology
Curated by ChEMBL
Development Center For Biotechnology
Curated by ChEMBL
Affinity DataIC50: 1.26E+4nMAssay Description:In vitro inhibitory concentration against SARS coronavirus main protease (SARS CoV 3C-like protease)More data for this Ligand-Target Pair
TargetReplicase polyprotein 1a(Human SARS coronavirus (SARS-CoV))
Development Center For Biotechnology
Curated by ChEMBL
Development Center For Biotechnology
Curated by ChEMBL
Affinity DataIC50: 1.31E+4nMAssay Description:In vitro inhibitory concentration against SARS coronavirus main protease (SARS CoV 3C-like protease)More data for this Ligand-Target Pair
TargetReplicase polyprotein 1a(Human SARS coronavirus (SARS-CoV))
Development Center For Biotechnology
Curated by ChEMBL
Development Center For Biotechnology
Curated by ChEMBL
Affinity DataIC50: 1.35E+4nMAssay Description:In vitro inhibitory concentration against SARS coronavirus main protease (SARS CoV 3C-like protease) at 20 uMMore data for this Ligand-Target Pair
TargetReplicase polyprotein 1a(Human SARS coronavirus (SARS-CoV))
Development Center For Biotechnology
Curated by ChEMBL
Development Center For Biotechnology
Curated by ChEMBL
Affinity DataIC50: 1.75E+4nMAssay Description:In vitro inhibitory concentration against SARS coronavirus main protease (SARS CoV 3C-like protease)More data for this Ligand-Target Pair
TargetReplicase polyprotein 1a(Human SARS coronavirus (SARS-CoV))
Development Center For Biotechnology
Curated by ChEMBL
Development Center For Biotechnology
Curated by ChEMBL
Affinity DataIC50: 2.35E+4nMAssay Description:In vitro inhibitory concentration against SARS coronavirus main protease (SARS CoV 3C-like protease)More data for this Ligand-Target Pair
Affinity DataIC50: 6.29E+4nMAssay Description:Inhibition of human topoisomerase 1More data for this Ligand-Target Pair
Affinity DataEC50: 4.00E+4nMAssay Description:Effective concentration required for cyclic AMP dependent inhibition of blood platelet aggregation for A2 receptor stimulationMore data for this Ligand-Target Pair